即嗨比分即嗨号

如何买球赛跟着庄家

The Arctic Group is a leading, independent provider of financial services

龙8国际娱乐网站_long8龙8国际首页_龙8娱乐app

可以买球赛的app叫0多少

Want a career at Arctic?


Apply now
网上买球算赌博吗

Coronavirus (COVID-19) company policy

Arctic's response to the coronavirus situation

Read More
即嗨足球比分

Download the
Arctic Circle app

足球竞彩 app
西甲外围买球app

Bestill LEI-nummer

Imøtekom kravet for investeringsselskap i 2018

Les mer

Update Client Information

For those who have received a request to update their client information.

Update now

龙8国际娱乐网站_long8龙8国际首页_龙8娱乐app

龙8国际娱乐网站_long8龙8国际首页_龙8娱乐app

彩客网足球专家推荐分析
Fri 04 Sep 2020

Job Openings - Arctic Securities, Stockholm - Internship 2021

Arctic Securities knows that high aspirations and strong motivation are keys to success. In Arctic we nourish our young talent and lay the foundation for Arctic Securities continued success. We want our company to be the place you want to work. We want you to love your job. Because when you love your job, you’ll do great things.

竞彩篮球过关方式
Thu 10 Sep 2020

Offerings - Nel ASA - Subsequent Offering

Arctic Securities is acting as Manager in relation to the Subsequent Offering in Nel ASA

买球主场怎么看
Thu 10 Sep 2020

News - Crucial late-stage milestone passed in treatment of rare pediatric liver disease

On Tuesday this week Arctic Aurora LifeScience portfolio company Albireo Pharma announced positive data from a Phase 3 trial with their drug candidate odevixibat in children and adolescents that suffer from the severely debilitating liver disease Progressive Familial Intrahepatic Cholestasis or PFIC. The Boston, Massachusetts headquartered company with an operational office in Gothenburg, Sweden, will now seek regulatory approvals for the commercial launch of odevixibat in PFIC.

竞彩足球彩票购买
Sat 01 Aug 2020

Offerings - ExpreS2ion Biotech Holding AB (publ) – Rights issue of SEK 131m

Arctic Securities is acting as financial advisor in relation to the rights issue in ExpreS2ion Biotech Holding AB (publ). ExpreS2ion Biotech Holding AB (publ) is referred to as “Expres2ion” or “the Company”. Shareholders have pre-emptive rights to subscribe for units. Three (1) existing shares held on the record date of October 1, 2020 entitles to one (1) unit consisting of two (2) new shares and one (1) warrant of series TO4 free of charge and one (1) warrant of series TO5 free of charge. Subscription price of SEK 24 per unit, corresponding to SEK 12 per share. The subscription period runs October 5 – October 19, 2020. Three (3) warrants of series TO4 entitles the holder to subscribe for one (1) share in the Company during the period from April 12, 2021 to April 26, 2021. Strike price for warrants will correspond to 70 percent of the VWAP of the Company's share on Nasdaq First North Growth Market during the period from March 29, 2021 to April 9, 2021, but at least SEK 6 and a maximum of SEK 22 per share. Three (3) warrants of series TO5 entitles the holder to subscribe for one (1) share in the Company during the period from September 6, 2021 to September 20, 2021. Strike price for warrants will correspond to 70 percent of the VWAP of the Company's share on Nasdaq First North Growth Market during the period from August 23, 2021 to September 3, 2021, but at least SEK 6 and a maximum of SEK 25 per share. The rights issue is secured up to 100 percent through subscription- and guarantee undertakings. A Swedish prospectus and subscription note will be available before the subscription period on Expres2ion’s website, www.expres2ionbio.com and Arctic Securities website.

龙8国际娱乐网站_long8龙8国际首页_龙8娱乐app

; 龙8国际娱乐网站_long8龙8国际首页_龙8娱乐app ||